Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,790,000 | 8,186,000 | 5,420,000 | 4,659,000 | 3,392,000 |
| Depreciation Amortization | 1,487,000 | 5,200,000 | 4,084,000 | 2,712,000 | 1,271,000 |
| Income taxes - deferred | 544,000 | -2,788,000 | -1,969,000 | -951,000 | -268,000 |
| Accounts receivable | N/A | -320,000 | N/A | N/A | N/A |
| Other Working Capital | -2,262,000 | -800,000 | -1,180,000 | -2,019,000 | -3,587,000 |
| Other Operating Activity | 712,000 | 3,875,000 | 3,231,000 | 507,000 | 435,000 |
| Operating Cash Flow | $3,271,000 | $13,353,000 | $9,586,000 | $4,908,000 | $1,243,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,831,000 | 4,862,000 | 6,820,000 | 6,363,000 | 6,202,000 |
| PPE Investments | -483,000 | -1,880,000 | -1,218,000 | -757,000 | -329,000 |
| Net Acquisitions | -610,000 | -464,000 | -464,000 | -463,000 | -456,000 |
| Purchase Of Investment | -498,000 | -1,635,000 | -1,406,000 | -1,243,000 | -1,158,000 |
| Sale Of Investment | 42,000 | 172,000 | 173,000 | 22,000 | 5,000 |
| Other Investing Activity | -104,000 | -260,000 | -311,000 | -375,000 | 7,000 |
| Investing Cash Flow | $-5,484,000 | $795,000 | $3,594,000 | $3,547,000 | $4,271,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,899,000 | 3,155,000 | 130,000 | 78,000 | 162,000 |
| Debt Issued | 602,000 | 2,573,000 | 1,243,000 | 1,243,000 | 19,000 |
| Debt Repayment | -561,000 | -64,000 | -61,000 | -60,000 | -58,000 |
| Common Stock Issued | 1,000 | 459,000 | 537,000 | 383,000 | 290,000 |
| Common Stock Repurchased | N/A | -9,994,000 | -7,494,000 | -4,999,000 | -2,500,000 |
| Dividend Paid | -2,138,000 | -7,975,000 | -6,021,000 | -4,040,000 | -2,032,000 |
| Other Financing Activity | -1,955,000 | -764,000 | -744,000 | -763,000 | -729,000 |
| Financing Cash Flow | $848,000 | $-12,610,000 | $-12,410,000 | $-8,158,000 | $-4,848,000 |
| Exchange Rate Effect | -28,000 | 41,000 | 14,000 | 14,000 | -1,000 |
| Beginning Cash Position | 3,406,000 | 1,827,000 | 1,827,000 | 1,827,000 | 1,827,000 |
| End Cash Position | 2,013,000 | 3,406,000 | 2,611,000 | 2,138,000 | 2,492,000 |
| Net Cash Flow | $-1,393,000 | $1,579,000 | $784,000 | $311,000 | $665,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,271,000 | 13,353,000 | 9,586,000 | 4,908,000 | 1,243,000 |
| Capital Expenditure | -483,000 | -1,880,000 | -1,218,000 | -757,000 | -329,000 |
| Free Cash Flow | 2,788,000 | 11,473,000 | 8,368,000 | 4,151,000 | 914,000 |